MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-MP-10-0010819
Market Cap
₹1,158 Cr
3BBLACKBIO · NSE
Share Price
₹1,334.40
-1.10% today
Revenue
₹142 Cr
FY 2025-26 · +47.1% YoY
EBITDA
₹56.78 Cr
Margin 40.0%
Net Profit
₹58.59 Cr
FY 2025-26 · +22.9% YoY
P/E (TTM)
20.4x
P/B 3.5x
Authorised capital
₹16.2 Cr
Registered with MCA
Paid-up capital
₹8.58 Cr
Issued & subscribed
About 3B Blackbio DX Limited
Data last updated:
3B Blackbio DX Limited is a public limited company based in Bhopal, Madhya Pradesh, India. It operates in the crop protection segment of the agriculture sector. It was incorporated on 27 May 1972 and has been in existence for over 54 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN L24211MP1972PLC001131. Its GSTIN is 23AABCK3873D1ZU (Madhya Pradesh). The company holds 4 GST registrations, of which 3 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 532067 and NSE: 3BBLACKBIO.
The company has an authorised share capital of ₹16.2 Cr and a paid-up capital of ₹8.58 Cr. It was formerly known as Kilpest Private Limited. It is led by directors including Dhirendra Dubey (Managing Director) and Nikhil Kuber Dubey (Whole-Time Director).
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 7 C Industiral Area Govindpura, Bhopal, Madhya Pradesh, India – 462023.
As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹141.92 Cr, a growth of 47.1% compared to the previous year. For the same year it recorded a net profit of ₹58.59 Cr (net margin 41.3%) and EBITDA of ₹56.78 Cr (EBITDA margin 40%).
The company has about 78 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 1 brand: Kilpest. As per MCA filings, the company has open charges of ₹12.72 Cr and satisfied charges of ₹4.88 Cr on record. Court records list 20 cases involving the company, including 13 filed by the company and 7 filed against it; 3 cases are pending. The company has 78 deals on record (77 market trades, 1 secondary share transfer); the latest was in February 2021. Its 5 peer companies in the Agriculture industry (Fertilizers, Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 2 smaller; the largest is Kisan Phosphates Private Limited with revenue of ₹114.74 Cr. The company has 6 MSME Form 1 returns on record between 2019 and 2022, listing 51 overdue payments to 25 micro and small suppliers.
3B Blackbio DX Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-MP-10-0010819). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website kilpest.com.
Company details
CIN L24211MP1972PLC001131
Registration Number 001131
Incorporation Date 27 May 1972
ROC Gwalior
Listing Status Listed - Listed on NSE (3BBLACKBIO); Listed on BSE (532067)
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-MP-10-0010819
CIN history
3B Blackbio DX has one previous CIN (Corporate Identification Number): U24211MP1972PLC001131. The current CIN is L24211MP1972PLC001131, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L24211MP1972PLC001131 | Current |
| U24211MP1972PLC001131 | Previous |
Key People
Dhirendra Dubey Managing Director Nikhil Kuber Dubey Whole-Time Director Abdul Moin Khan Director Recognitions & Rankings of 3B Blackbio DX
Contact details
3B Blackbio DX Limited's registered office is in Bhopal, Madhya Pradesh. Its website is kilpest.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address7 C Industiral Area Govindpura, Bhopal, Madhya Pradesh, India – 462023
- IndustryAgriculture, Crop Protection, Fertilizers & Soil Enhancers
To see the full contact details of 3B Blackbio DX Limited, buy the company report.
Comprehensive company report
3B Blackbio DX Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
3B Blackbio DX operates one associated brand: Kilpest. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturer of agricultural and diagnostic products | kilpest.com |
Business activity
The main business activity of 3B Blackbio DX is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of 3B Blackbio DX Limited, buy the company report.
Financials of 3B Blackbio DX Limited
FY 2025-26 filings available3B Blackbio DX Limited reported revenue of ₹141.92 Cr (up 47.1% YoY) for FY 2025-26.
Financial Highlights
FY 2025-26 · ConsolidatedRevenue
₹142 Cr
+47.1% YoY
EBITDA
₹56.78 Cr
+13.3% YoY
Profit After Tax
₹58.59 Cr
+22.9% YoY
Net Worth
-
Total Assets
-
Total Debt
-
Revenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 142 | 96.47 | 74.12 | 61.84 | 80.65 | 227 | 28.87 |
| Revenue growth | +47.1% | +30.2% | +19.9% | -23.3% | -64.4% | +685.4% | - |
| EBITDA | 56.78 | 50.11 | 32.98 | 29.12 | 37.10 | 150 | 9.32 |
| EBITDA margin | +40.0% | +51.9% | +44.5% | +47.1% | +46.0% | +66.2% | +32.3% |
| Profit before tax | 76.97 | 63.99 | 44.33 | 35.32 | 43.22 | 152 | 10.05 |
| Net profit | 58.59 | 47.67 | 32.09 | 25.83 | 32.19 | 114 | 7.69 |
| Net profit margin | +41.3% | +49.4% | +43.3% | +41.8% | +39.9% | +50.2% | +26.6% |
| EPS (₹) | 69.94 | 55.66 | 37.46 | 30.28 | 42.98 | 152.00 | 10.26 |
| Balance sheet | |||||||
| Total assets | - | 271 | 226 | 198 | 175 | 150 | 37.78 |
| Net worth | - | 268 | 223 | 193 | 153 | 132 | 32.11 |
| Total debt | - | 0.31 | 0.85 | 2.03 | 2.53 | 2.01 | 3.52 |
| Cash & bank | - | 68.83 | 62.15 | 59.21 | 28.89 | 35.08 | 9.38 |
| Net working capital | - | 114 | 106 | 101 | 66.33 | 76.40 | 33.23 |
| Cash flow | |||||||
| Cash from operations | - | 43.36 | 26.95 | 20.28 | 37.33 | 97.52 | 7.04 |
| Cash from investing | - | (33.45) | (20.38) | 15.04 | (28.44) | (70.26) | (0.64) |
| Cash from financing | - | (3.22) | (3.63) | (5.01) | (15.07) | (1.57) | 0.81 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 33.49 | 35.43 | 50.35 | 33.90 | 22.23 | 22.50 | 25.39 | 29.15 |
| Revenue growth (YoY) | +50.7% | +57.5% | +98.3% | +16.3% | +14.4% | - | - | - |
| Other income | 6.14 | 10.15 | 5.59 | 5.51 | 4.32 | 4.94 | 3.01 | 3.44 |
| EBITDA | 8.52 | 8.49 | 21.72 | 14.73 | 11.83 | 7.93 | 15.07 | 16.18 |
| EBITDA margin | +25.4% | +24.0% | +43.1% | +43.5% | +53.2% | +35.2% | +59.4% | +55.5% |
| Depreciation | 1.34 | 3.89 | 0.38 | 0.58 | 0.28 | 0.28 | 0.27 | 0.27 |
| Interest | 0.10 | 0.10 | 0.09 | 0.04 | 0.01 | 0.04 | 0.02 | 0.03 |
| Profit before tax | 13.22 | 14.65 | 26.84 | 19.62 | 15.86 | 12.55 | 17.79 | 19.32 |
| Tax | 4.24 | 4.85 | 4.40 | 4.58 | 3.22 | 4.50 | 4.30 | 4.44 |
| Net profit | 8.98 | 9.80 | 22.44 | 15.04 | 12.64 | 8.05 | 13.49 | 14.88 |
| EPS (₹) | 10.48 | 11.44 | 26.19 | 17.55 | 14.76 | 9.38 | 15.75 | 17.35 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 97.28 | 90.53 | 70.72 | 59.34 | 15.52 | 14.36 | 13.51 |
| Revenue growth | +7.5% | +28.0% | +19.2% | +282.4% | +8.1% | +6.3% | - |
| EBITDA | 53.19 | 49.85 | 35.11 | 29.59 | (1.23) | (1.22) | (0.25) |
| EBITDA margin | +54.7% | +55.1% | +49.7% | +49.9% | -7.9% | -8.5% | -1.9% |
| Profit before tax | 66.37 | 63.92 | 46.45 | 35.85 | 8.46 | 2.07 | 0.60 |
| Net profit | 49.33 | 47.53 | 34.21 | 26.31 | 8.00 | 1.70 | 0.60 |
| Net profit margin | +50.7% | +52.5% | +48.4% | +44.3% | +51.6% | +11.8% | +4.4% |
| EPS (₹) | 57.56 | 55.51 | 39.93 | 30.85 | 10.69 | 2.29 | 0.82 |
| Balance sheet | |||||||
| Total assets | 319 | 273 | 228 | 198 | 26.46 | 24.66 | 24.30 |
| Net worth | 319 | 273 | 228 | 196 | 23.93 | 22.65 | 20.78 |
| Total debt | 0.00 | 0.31 | 0.71 | 2.03 | 2.53 | 2.01 | 3.52 |
| Cash & bank | 79.10 | 62.63 | 54.88 | 50.35 | 1.85 | 1.71 | 0.69 |
| Net working capital | 128 | 106 | 98.59 | 91.84 | 20.17 | 19.32 | 18.96 |
| Cash flow | |||||||
| Cash from operations | 42.82 | 44.47 | 28.47 | 21.16 | 7.98 | 2.79 | 1.10 |
| Cash from investing | (19.80) | (33.64) | (20.32) | (7.80) | (1.52) | (0.17) | (2.45) |
| Cash from financing | (6.55) | (3.07) | (3.62) | (2.89) | (6.31) | (1.59) | 1.42 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 22.95 | 24.63 | 24.38 | 27.91 | 20.36 | 23.02 | 23.43 | 26.57 |
| Revenue growth (YoY) | +12.7% | +7.0% | +4.1% | +5.0% | +16.3% | - | - | - |
| Other income | 5.30 | 1.30 | 4.63 | 3.91 | 4.31 | 4.91 | 3.01 | 3.43 |
| Total expenses | 9.66 | 13.35 | 9.91 | 12.07 | 8.77 | 13.56 | 8.46 | 11.48 |
| EBITDA | 13.29 | 11.28 | 14.47 | 15.84 | 11.59 | 9.46 | 14.97 | 15.09 |
| EBITDA margin | +57.9% | +45.8% | +59.4% | +56.8% | +56.9% | +41.1% | +63.9% | +56.8% |
| Depreciation | 0.24 | 0.29 | 0.22 | 0.22 | 0.22 | 0.20 | 0.22 | 0.22 |
| Interest | 0.00 | 0.00 | 0.02 | 0.01 | 0.01 | 0.03 | 0.02 | 0.03 |
| Profit before tax | 18.35 | 12.29 | 18.86 | 19.52 | 15.67 | 14.14 | 17.74 | 18.27 |
| Tax | 4.24 | 4.85 | 4.40 | 4.58 | 3.22 | 4.90 | 4.28 | 4.13 |
Financial Statements
Figures in ₹ Cr; negatives in brackets. Updated 24 Oct 2026
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 33.49 | 35.43 | 50.35 | 33.90 | 22.23 | 22.50 | 25.39 | 29.15 |
| Revenue growth (YoY) | +50.7% | +57.5% | +98.3% | +16.3% | +14.4% | - | - | - |
| Other income | 6.14 | 10.15 | 5.59 | 5.51 | 4.32 | 4.94 | 3.01 | 3.44 |
| EBITDA | 8.52 | 8.49 | 21.72 | 14.73 | 11.83 | 7.93 | 15.07 | 16.18 |
| EBITDA margin | +25.4% | +24.0% | +43.1% | +43.5% | +53.2% | +35.2% | +59.4% | +55.5% |
| Depreciation | 1.34 | 3.89 | 0.38 | 0.58 | 0.28 | 0.28 | 0.27 | 0.27 |
| Interest | 0.10 | 0.10 | 0.09 | 0.04 | 0.01 | 0.04 | 0.02 | 0.03 |
| Profit before tax | 13.22 | 14.65 | 26.84 | 19.62 | 15.86 | 12.55 | 17.79 | 19.32 |
| Tax | 4.24 | 4.85 | 4.40 | 4.58 | 3.22 | 4.50 | 4.30 | 4.44 |
| Net profit | 8.98 | 9.80 | 22.44 | 15.04 | 12.64 | 8.05 | 13.49 | 14.88 |
| EPS (₹) | 10.48 | 11.44 | 26.19 | 17.55 | 14.76 | 9.38 | 15.75 | 17.35 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 142 | 96.47 | 74.12 | 61.84 | 80.65 | 227 | 28.87 |
| Revenue growth | +47.1% | +30.2% | +19.9% | -23.3% | -64.4% | +685.4% | - |
| Other income | 25.56 | 15.08 | 12.53 | 7.26 | 6.90 | 2.89 | 1.60 |
| Total expenses | 85.14 | 46.36 | 41.14 | 32.72 | 43.55 | 76.76 | 19.55 |
| Employee cost | 0.00 | 7.32 | 6.50 | 5.03 | 3.81 | 4.67 | 2.85 |
| EBITDA | 56.78 | 50.11 | 32.98 | 29.12 | 37.10 | 150 | 9.32 |
| EBITDA margin | +40.0% | +51.9% | +44.5% | +47.1% | +46.0% | +66.2% | +32.3% |
| Depreciation | 5.13 | 1.09 | 1.06 | 0.86 | 0.67 | 0.62 | 0.54 |
| Interest | 0.24 | 0.11 | 0.12 | 0.20 | 0.11 | 0.23 | 0.33 |
| Profit before tax | 76.97 | 63.99 | 44.33 | 35.32 | 43.22 | 152 | 10.05 |
| Tax | 17.04 | 16.30 | 12.23 | 9.37 | 11.03 | 38.17 | 2.36 |
| Net profit | 58.59 | 47.67 | 32.09 | 25.83 | 32.19 | 114 | 7.69 |
| Net profit margin | +41.3% | +49.4% | +43.3% | +41.8% | +39.9% | +50.2% | +26.6% |
| EPS (₹) | 69.94 | 55.66 | 37.46 | 30.28 | 42.98 | 152.00 | 10.26 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | - | 8.57 | 8.57 | 8.57 | 7.49 | 7.49 | 7.49 |
| Reserves & surplus | - | 260 | 214 | 185 | 146 | 125 | 24.62 |
| Shareholders' funds (net worth) | - | 268 | 223 | 193 | 153 | 132 | 32.11 |
| Minority interest | - | 2.58 | 2.42 | 2.65 | 19.05 | 16.22 | 2.14 |
| Secured loans | - | 0.00 | 0.06 | 1.12 | 1.69 | 0.99 | 2.13 |
| Unsecured loans | - | 0.31 | 0.79 | 0.91 | 0.84 | 1.02 | 1.39 |
| Total debt | - | 0.31 | 0.85 | 2.03 | 2.53 | 2.01 | 3.52 |
| Total liabilities | - | 271 | 226 | 198 | 175 | 150 | 37.78 |
| Assets | |||||||
| Gross block | - | 15.01 | 14.11 | 14.08 | 11.99 | 10.51 | 8.76 |
| Net block | - | 7.22 | 7.40 | 7.79 | 6.61 | 5.00 | 3.87 |
| Capital work in progress | - | 0.00 | 0.00 | 0.09 | 0.11 | 0.13 | 0.20 |
| Investments | - | 156 | 117 | 91.71 | 92.64 | 58.81 | 1.20 |
| Inventories | - | 8.74 | 8.43 | 8.04 | 7.43 | 4.87 | 4.07 |
| Sundry debtors | - | 36.52 | 36.25 | 33.94 | 29.98 | 34.79 | 19.93 |
| Cash & bank balances | - | 68.83 | 62.15 | 59.21 | 28.89 | 35.08 | 9.38 |
| Loans & advances | - | 18.10 | 16.57 | 13.05 | 15.24 | 43.64 | 5.95 |
| Total current assets | - | 132 | 123 | 114 | 81.54 | 118 | 39.33 |
| Total current liabilities | - | 18.59 | 17.47 | 13.07 | 15.21 | 41.98 | 6.10 |
| Net working capital | - | 114 | 106 | 101 | 66.33 | 76.40 | 33.23 |
| Total assets | - | 271 | 226 | 198 | 175 | 150 | 37.78 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | - | 62.15 | 59.21 | 28.89 | 35.08 | 9.38 | 2.17 |
| Net cash from operating activities | - | 43.36 | 26.95 | 20.28 | 37.33 | 97.52 | 7.04 |
| Net cash from investing activities | - | (33.45) | (20.38) | 15.04 | (28.44) | (70.26) | (0.64) |
| Net cash from financing activities | - | (3.22) | (3.63) | (5.01) | (15.07) | (1.57) | 0.81 |
| Net change in cash | - | 6.68 | 2.94 | 30.31 | (6.19) | 25.70 | 7.21 |
| Closing cash | - | 68.83 | 62.15 | 59.21 | 28.89 | 35.08 | 9.38 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +47.1% | +30.2% | +19.9% | -23.3% | -64.4% | +685.4% | - |
| EBITDA growth | +13.3% | +51.9% | +13.3% | -21.5% | -75.3% | +1509.2% | - |
| PBT growth | +20.3% | +44.4% | +25.5% | -18.3% | -71.6% | +1412.6% | +44.4% |
| Net income growth | +22.9% | +48.6% | +24.2% | -19.8% | -71.7% | +1380.5% | - |
| Revenue CAGR (3Y) | +31.9% | +6.2% | -31.1% | +28.9% | +51.3% | +113.8% | +21.3% |
| EBITDA CAGR (3Y) | +24.9% | +10.5% | -39.6% | +46.2% | +72.5% | +202.5% | +54.0% |
| Profitability & leverage | |||||||
| Net income margin | +42.2% | +49.4% | +43.3% | +42.0% | +39.9% | +50.2% | +26.6% |
| Return on capital employed | - | +26.0% | +21.2% | +20.2% | +29.9% | +179.5% | +32.3% |
| Return on net worth | - | +19.4% | +15.4% | +15.0% | +22.6% | +138.7% | +28.2% |
| Debt / equity | - | 0.00 | 0.01 | 0.01 | 0.02 | 0.03 | 0.18 |
| Long-term debt / equity | - | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.07 |
| Interest cover | 0.46 | 0.22 | 0.38 | 0.71 | 0.30 | 0.15 | 3.76 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 6.63 | 5.26 | 4.74 | 7.17 | 23.53 | 3.38 |
| Inventory turnover | - | 11.24 | 9.00 | 7.99 | 13.11 | 50.72 | 6.37 |
| Debtors turnover | - | 2.65 | 2.11 | 1.93 | 2.49 | 8.29 | 1.50 |
| EPS (₹) | 69.94 | 55.66 | 37.46 | 30.28 | 42.98 | 152.00 | 10.26 |
| Dividend per share (₹) | 5.00 | 4.00 | 3.00 | 2.50 | 10.50 | 9.00 | 0.70 |
| Book value per share (₹) | 0.00 | 313.27 | 260.32 | 225.60 | 204.26 | 176.27 | 42.87 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 22.95 | 24.63 | 24.38 | 27.91 | 20.36 | 23.02 | 23.43 | 26.57 |
| Revenue growth (YoY) | +12.7% | +7.0% | +4.1% | +5.0% | +16.3% | - | - | - |
| Other income | 5.30 | 1.30 | 4.63 | 3.91 | 4.31 | 4.91 | 3.01 | 3.43 |
| Total expenses | 9.66 | 13.35 | 9.91 | 12.07 | 8.77 | 13.56 | 8.46 | 11.48 |
| EBITDA | 13.29 | 11.28 | 14.47 | 15.84 | 11.59 | 9.46 | 14.97 | 15.09 |
| EBITDA margin | +57.9% | +45.8% | +59.4% | +56.8% | +56.9% | +41.1% | +63.9% | +56.8% |
| Depreciation | 0.24 | 0.29 | 0.22 | 0.22 | 0.22 | 0.20 | 0.22 | 0.22 |
| Interest | 0.00 | 0.00 | 0.02 | 0.01 | 0.01 | 0.03 | 0.02 | 0.03 |
| Profit before tax | 18.35 | 12.29 | 18.86 | 19.52 | 15.67 | 14.14 | 17.74 | 18.27 |
| Tax | 4.24 | 4.85 | 4.40 | 4.58 | 3.22 | 4.90 | 4.28 | 4.13 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 97.28 | 90.53 | 70.72 | 59.34 | 15.52 | 14.36 | 13.51 |
| Revenue growth | +7.5% | +28.0% | +19.2% | +282.4% | +8.1% | +6.3% | - |
| Other income | 14.16 | 15.03 | 12.32 | 7.26 | 10.09 | 3.72 | 1.40 |
| Total expenses | 44.09 | 40.68 | 35.61 | 29.75 | 16.75 | 15.58 | 13.76 |
| Employee cost | 0.00 | 6.21 | 5.14 | 4.01 | 1.82 | 1.64 | 1.52 |
| EBITDA | 53.19 | 49.85 | 35.11 | 29.59 | (1.23) | (1.22) | (0.25) |
| EBITDA margin | +54.7% | +55.1% | +49.7% | +49.9% | -7.9% | -8.5% | -1.9% |
| Depreciation | 0.94 | 0.86 | 0.87 | 0.80 | 0.29 | 0.20 | 0.22 |
| Interest | 0.04 | 0.10 | 0.11 | 0.20 | 0.11 | 0.23 | 0.33 |
| Profit before tax | 66.37 | 63.92 | 46.45 | 35.85 | 8.46 | 2.07 | 0.60 |
| Tax | 17.04 | 16.37 | 12.23 | 9.42 | 0.46 | 0.37 | 0.00 |
| Net profit | 49.33 | 47.53 | 34.21 | 26.31 | 8.00 | 1.70 | 0.60 |
| Net profit margin | +50.7% | +52.5% | +48.4% | +44.3% | +51.6% | +11.8% | +4.4% |
| EPS (₹) | 57.56 | 55.51 | 39.93 | 30.85 | 10.69 | 2.29 | 0.82 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 8.57 | 8.57 | 8.57 | 8.57 | 7.49 | 7.49 | 7.49 |
| Reserves & surplus | 310 | 264 | 219 | 188 | 16.44 | 15.16 | 13.29 |
| Shareholders' funds (net worth) | 319 | 273 | 228 | 196 | 23.93 | 22.65 | 20.78 |
| Secured loans | 0.00 | 0.00 | 0.00 | 1.12 | 1.69 | 0.99 | 2.13 |
| Unsecured loans | 0.00 | 0.31 | 0.71 | 0.91 | 0.84 | 1.02 | 1.39 |
| Total debt | 0.00 | 0.31 | 0.71 | 2.03 | 2.53 | 2.01 | 3.52 |
| Total liabilities | 319 | 273 | 228 | 198 | 26.46 | 24.66 | 24.30 |
| Assets | |||||||
| Gross block | 15.06 | 13.68 | 12.98 | 13.01 | 7.54 | 6.00 | 5.79 |
| Net block | 6.81 | 6.37 | 6.53 | 6.79 | 3.23 | 1.97 | 1.97 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.09 | 0.11 | 0.13 | 0.20 |
| Investments | 188 | 167 | 128 | 102 | 3.60 | 3.60 | 3.60 |
| Inventories | 6.57 | 8.14 | 7.97 | 7.63 | 2.66 | 2.71 | 3.22 |
| Sundry debtors | 43.20 | 35.18 | 36.47 | 33.43 | 14.35 | 14.09 | 14.15 |
| Cash & bank balances | 79.10 | 62.63 | 54.88 | 50.35 | 1.85 | 1.71 | 0.69 |
| Loans & advances | 23.49 | 18.10 | 16.28 | 13.05 | 5.54 | 4.42 | 4.12 |
| Total current assets | 152 | 124 | 116 | 104 | 24.40 | 22.93 | 22.18 |
| Total current liabilities | 24.66 | 18.21 | 17.01 | 12.62 | 4.23 | 3.61 | 3.22 |
| Net working capital | 128 | 106 | 98.59 | 91.84 | 20.17 | 19.32 | 18.96 |
| Total assets | 319 | 273 | 228 | 198 | 26.46 | 24.66 | 24.30 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 62.63 | 54.88 | 50.35 | 39.89 | 1.71 | 0.69 | 0.62 |
| Net cash from operating activities | 42.82 | 44.47 | 28.47 | 21.16 | 7.98 | 2.79 | 1.10 |
| Net cash from investing activities | (19.80) | (33.64) | (20.32) | (7.80) | (1.52) | (0.17) | (2.45) |
| Net cash from financing activities | (6.55) | (3.07) | (3.62) | (2.89) | (6.31) | (1.59) | 1.42 |
| Net change in cash | 16.47 | 7.76 | 4.53 | 10.46 | 0.14 | 1.02 | 0.07 |
| Closing cash | 79.10 | 62.63 | 54.88 | 50.35 | 1.85 | 1.71 | 0.69 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +7.5% | +28.0% | +19.2% | +282.4% | +8.1% | +6.3% | - |
| EBITDA growth | +6.7% | +42.0% | +18.7% | +2505.7% | -0.8% | -388.0% | - |
| PBT growth | +3.8% | +37.6% | +29.6% | +323.8% | +308.7% | +245.0% | +36.4% |
| Net income growth | +3.8% | +38.9% | +30.0% | +228.9% | +370.6% | +183.3% | - |
| Revenue CAGR (3Y) | +17.9% | +80.0% | +70.1% | +63.8% | +8.7% | -2.6% | +1.3% |
| EBITDA CAGR (3Y) | +21.6% | - | - | - | - | - | - |
| Profitability & leverage | |||||||
| Net income margin | +50.7% | +52.5% | +48.4% | +44.5% | +51.6% | +11.8% | +4.4% |
| Return on capital employed | - | +25.5% | +21.8% | +32.1% | +33.6% | +9.5% | +4.1% |
| Return on net worth | - | +19.0% | +16.1% | +24.0% | +34.4% | +7.9% | +3.3% |
| Debt / equity | - | 0.00 | 0.01 | 0.02 | 0.10 | 0.13 | 0.27 |
| Long-term debt / equity | - | 0.00 | 0.00 | 0.01 | 0.04 | 0.06 | 0.10 |
| Interest cover | 0.08 | 0.20 | 0.32 | 0.69 | -7.24 | -16.20 | -70.21 |
| Efficiency & per share | |||||||
| Fixed asset turnover | - | 6.79 | 5.44 | 5.78 | 2.29 | 2.44 | 2.34 |
| Inventory turnover | - | 11.24 | 9.07 | 11.53 | 5.78 | 4.84 | 3.66 |
| Debtors turnover | - | 2.53 | 2.02 | 2.48 | 1.09 | 1.02 | 0.96 |
| EPS (₹) | 57.56 | 55.51 | 39.93 | 30.85 | 10.69 | 2.29 | 0.82 |
| Dividend per share (₹) | 5.00 | 4.00 | 3.00 | 2.50 | 10.50 | 9.00 | 0.70 |
| Book value per share (₹) | 0.00 | 318.36 | 265.84 | 228.91 | 31.94 | 30.24 | 27.74 |
To see the full year-wise statements and ratios of 3B Blackbio DX Limited, buy the company report.
Board of directors of 3B Blackbio DX Limited
3B Blackbio DX has 6 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abdul Moin Khan | Director | 25 Sep 2017 | 9 Years 0 Months | Current |
| Harihar Prasad Thapak | Director | 23 Sep 2022 | 4 Years 1 Months | Current |
| Nikhil Kuber Dubey Also directs: Mithala Laboratoreis Pvt Ltd | Whole-Time Director | 11 Aug 1993 | 33 Years 2 Months | Current |
| Dhirendra Dubey | Managing Director | 01 Jul 1995 | 31 Years 3 Months | Current |
| Mithla Dubey Also directs: Mithala Laboratoreis Pvt Ltd | Director | 27 Mar 2015 | 11 Years 6 Months | Current |
| Vivek Saihgal | Director | 14 Aug 2025 | 1 Years 2 Months | Current |
Peer comparison
3B Blackbio DX Limited is compared with the 5 companies closest to it by revenue in the Agriculture industry (Fertilizers, Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| 3B Blackbio DX Limitedthis company | ₹141.92 Cr (FY 2026) | ₹58.59 Cr | 41.3% | 47.1% | 78 | Bhopal, Madhya Pradesh, India |
| Kisan Phosphates Private Limited | ₹114.74 Cr (FY 2025) | 15.0% | Mumbai, Maharashtra, India | |||
| Plant Remedies Private Limited | ₹113.82 Cr (FY 2025) | 73.0% | Patna, Bihar, India | |||
| Leeds Life Sciences Private Limited | ₹112.32 Cr (FY 2025) | 7.0% | New Delhi, Delhi, India | |||
| Netmatrix Crop Care Private Limited | ₹106.6 Cr (FY 2025) | 20.0% | Hyderabad, Telangana, India | |||
| Swastik Pesticides Limited | ₹106.54 Cr (FY 2025) | 3.0% | New Delhi, Delhi, India |
To see the full peer comparison of 3B Blackbio DX Limited, buy the company report.
Auditor
3B Blackbio DX Limited is audited by BAHETI & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BAHETI & CO | FY 2023 | 006287C |
Shareholding
Shareholding for the quarter ended Sep 2026: promoters hold 41.00%, foreign institutional investors hold 2.50%, domestic institutional investors hold 2.10% and retail and other public shareholders hold 54.40%.
Sep 2026
QUARTER
41.00% Promoters
2.10% DII (Domestic Institutional)
2.50% FII (Foreign Institutional)
54.40% Retail & Others
Promoter holding - history
Now 41.00% · Sep 2026High 41.30% · Dec 2025Low 40.90% · Jun 2026
Shareholding trend - last 6 quarters
| Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | |
|---|---|---|---|---|
| Promoters | 41.00% | 40.90% | 41.30% | 41.30% |
| Public | 59.00% | 59.10% | 58.70% | 58.70% |
Charges & borrowings
Open charges
₹12.72 Cr
Satisfied charges
₹4.88 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Jun 2011 | 10295338 | State Bank of India | ₹25 Lakh | Open | |
| 05 Sep 1995 | 90210275 | 20 Th Centuray Finance Corp. Ltd. | ₹17 Lakh | Open | |
| 31 Mar 1992 | 90201572 | State Bank of India | ₹12.3 Cr | Open | |
| 15 Feb 2011 | 10270239 | State Bank of India | ₹35 Lakh | Satisfied | |
| 02 Dec 2009 | 10189836 | State Bank of Indore | ₹20 Lakh | Satisfied |
To see the full charge records of 3B Blackbio DX Limited, buy the company report.
Total charge records: 21 View all charges
Deals & funding
3B Blackbio DX Limited has 78 deals on record (77 market trades, 1 secondary share transfer); the latest was in February 2021.
Total deals
78
Market trades
77
Secondary share transfer
1
Deals on record (5 of 78)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Aug 2020 | Market trade | ₹11.84 Cr | Buyer: Alpha Leon Enterprises LLP , Lenus Finvest Private Limited Seller: Alpha Leon Enterprises LLP |
| Jul 2020 | Market trade | ₹18.36 Cr | Buyer: Seven Canyons World Innovators Fund Seller: Own Infracon Private Limited , an individual |
| Jul 2020 | Market trade | ₹3.41 Cr | Buyer: Alpha Leon Enterprises LLP Seller: Alpha Leon Enterprises LLP |
| Jun 2020 | Market trade | ₹2.81 Cr | Buyer: Arms Securities Private Limited |
| Jun 2020 | Market trade | ₹1.23 Cr | Buyer: Alpha Leon Enterprises LLP Seller: Alpha Leon Enterprises LLP |
To see the full deal history of 3B Blackbio DX Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
3B Blackbio DX Limited has 20 court cases on record: 13 filed by 3B Blackbio DX, 7 filed against it. 3 cases are pending and 17 are disposed.
Total cases
20
Filed by the company
13
Filed against the company
7
Pending
3
Disposed
17
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 14 | 3 | 0 |
| District courts | 6 | 4 | 3 |
Cases on record (5 of 20)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Kottayam, Kerala | Civil suit | Filed against the company by The Plantation Corporation of Kerala Ltd. | Disposed |
| District court, Bhopal, Madhya Pradesh | Court case (RCS B) | Filed by the company against M/S Hiya Scientific Solutions Through Its Pro. Suneel Sharma | Pending |
| District court, Bhopal, Madhya Pradesh | Court case (RCT) | Filed by the company against M/S Dev Spice Industries Proprietor Devdutt Sharma | Pending |
| District court, Thiruvananthapuram, Kerala | Civil suit | Filed against the company by State of Kerala (Collector) | Pending |
| District court, Vidisha, Madhya Pradesh | Court case (MJC) | Filed against the company by Cooperative Society | Disposed |
To see the full case history of 3B Blackbio DX Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
3B Blackbio DX Limited has 6 MSME Form 1 returns on record between 2019 and 2022, listing 51 overdue payments to 25 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 25)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| Rashmi Enterprises, Bhopal | |||
| Varteji Chemicals Bhavnagar | |||
| Mag Products (India) Private Limited | |||
| an individual supplier |
To see the full MSME payment records of 3B Blackbio DX Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
3B Blackbio DX has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| 3B Blackbio Biotech India Limited | U24232MP2010PTC024717 |
To see the full group structure of 3B Blackbio DX Limited, buy the company report.
Employees & EPFO
3B Blackbio DX Limited has a workforce of 78 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
Employee count
78
Active EPFO establishments
1
Employee growth
8.33%
GST
3B Blackbio DX has 4 GST registrations: 3 active and 1 cancelled or inactive.
Total GSTINs
4
Active
3
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AABCK3873D1ZU | Madhya Pradesh | Active | 01 Jul 2017 |
| 09AABCK3873D1ZK | Uttar Pradesh | Active | 01 Jul 2017 |
| 22AABCK3873D1ZW | Chhattisgarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of 3B Blackbio DX Limited, buy the company report.
Recent activity
3B Blackbio DX Limited has 18 board changes on record since 1972: 12 appointments and 6 cessations. The latest: Vivek Saihgal was appointed as Director on 14 Aug 2025.
Filing
3B Blackbio Dx Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Gwalior.
AGM
3B Blackbio Dx Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Appointed
Vivek Saihgal was appointed as Director.
Ceased
Rajesh Dubey ceased to be Director.
Ceased
Shabbar Husain ceased to be Director.
Appointed
Rajesh Dubey was appointed as Director.
Charges
A charge registered on 10 Aug 2009 via Charge ID 10172340 with State Bank Of Indore was fully satisfied on 13 Jan 2023.
Charges
A charge registered on 07 Nov 2008 via Charge ID 10129219 with State Bank Of Indore was fully satisfied on 13 Jan 2023.
Charges
A charge registered on 18 May 2007 via Charge ID 10053092 with State Bank Of Indore was fully satisfied on 13 Jan 2023.
Charges
A charge registered on 15 Dec 2006 via Charge ID 10035965 with State Bank Of Indore was fully satisfied on 13 Jan 2023.
Charges
A charge registered on 27 Dec 2004 via Charge ID 90204248 with State Bank Of Indore was fully satisfied on 13 Jan 2023.
Charges
A charge registered on 10 Mar 2000 via Charge ID 90205565 with State Bank Of Indore was fully satisfied on 13 Jan 2023.
61 earlier events are in the company report.
News
Frequently asked questions
3B Blackbio DX is an active public limited company based in Bhopal, Madhya Pradesh, India. The company works in crop protection, within the agriculture industry. It was incorporated on 27 May 1972 (54+ years old) and is registered under CIN L24211MP1972PLC001131. Listed on BSE: 532067 and NSE: 3BBLACKBIO.
3B Blackbio DX reported revenue of ₹141.92 Cr for FY 2025-26 (up 47.1% YoY) based on consolidated financials.
3B Blackbio DX has 6 current directors:
- Dhirendra Dubey - Managing Director
- Nikhil Kuber Dubey - Whole-Time Director
- Abdul Moin Khan - Director
- Harihar Prasad Thapak - Director
- Mithla Dubey - Director
- Vivek Saihgal - Director
The latest financial statements of 3B Blackbio DX on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 26 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of 3B Blackbio DX is 23AABCK3873D1ZU, registered in Madhya Pradesh. The company has 4 GST registrations in all, of which 3 are active and 1 is cancelled or inactive. Other active GSTINs include 09AABCK3873D1ZK (Uttar Pradesh), 22AABCK3873D1ZW (Chhattisgarh).
The CIN (Corporate Identification Number) of 3B Blackbio DX is L24211MP1972PLC001131. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Yes. 3B Blackbio DX is a listed company as per MCA records. Its shares are listed on both BSE (code: 532067) and NSE (symbol: 3BBLACKBIO).
3B Blackbio DX has 20 court cases on record: 13 filed by the company and 7 filed against it. 3 are pending. Most are in the high courts.
3B Blackbio DX was incorporated on 27 May 1972, making it 54+ years old. It is registered with the Registrar of Companies, Gwalior.
3B Blackbio DX has 78 deals on record (77 market trades, 1 secondary share transfer); the latest was in February 2021.
The peers of 3B Blackbio DX by revenue are Kisan Phosphates Private Limited, Plant Remedies Private Limited, Leeds Life Sciences Private Limited, Netmatrix Crop Care Private Limited, Swastik Pesticides Limited, all in the Agriculture industry (Fertilizers, Pesticides), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Vivek Saihgal was appointed as Director on 14 Aug 2025. Rajesh Dubey ceased to be Director on 13 Jul 2025. Shabbar Husain ceased to be Director on 29 Sep 2024. 3B Blackbio DX has 18 board changes on record in total.